Holoprosencephaly: recommendations for diagnosis and management

Emily F Kauvar1, Maximilian Muenke

  • 1Medical Genetics Branch, National Human Genome Research Institute, National Institutes of Health, Bethesda, Maryland 20892-3717, USA.

Insights

Holoprosencephaly (HPE) is a common forebrain developmental disorder. Advances in understanding HPE causes, like chromosomal abnormalities and maternal diabetes, aid clinical management and genetic counseling.

Area of Science:

  • Developmental Biology
  • Medical Genetics
  • Clinical Neurology

Background:

  • Holoprosencephaly (HPE) is the most frequent congenital disorder affecting the human forebrain.
  • It is characterized by the incomplete or failed separation of the cerebral hemispheres.
  • HPE presents a wide spectrum of midline defects and clinical manifestations.

Purpose of the Study:

  • To review recent advancements in understanding holoprosencephaly (HPE).
  • To discuss the clinical management of HPE.
  • To cover epidemiology, clinical features, causes, diagnosis, and outcomes of HPE.

Main Methods:

  • Review of recent literature on holoprosencephaly.
  • Analysis of epidemiological studies.
  • Discussion of genetic studies utilizing microarray-based comparative genomic hybridization.

Main Results:

  • Chromosomal abnormalities are the most frequent identified cause of HPE.
  • Unidentifiable causes exist in nonsyndromic, nonchromosomal forms.
  • Maternal pregestational diabetes mellitus is a significant risk factor.
  • Microarray technology has improved characterization of HPE loci.
  • HPE prevalence may be underestimated due to mild, undiagnosed cases.

Conclusions:

  • HPE involves a broad range of forebrain defects and clinical presentations.
  • A multidisciplinary team approach is essential for managing HPE.
  • Further research is crucial for understanding HPE pathogenesis and improving genetic counseling.
Abstract